KOSDAQ · Healthcare · ₩177B
₩2,975+2.59%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 4.6% · as of 26.10.27
Among 98 제약 peers
Quarterly Revenue Growth
“신약 출시 기반은 마련됐고, 이제 판매 확대를 확인할 차례예요.”
In the company's words · 2026 2분기 filing